ORIGINAL ARTICLE |
|
Year : 2017 | Volume
: 18
| Issue : 3 | Page : 77-82 |
|
Gender differences among patients with acute coronary syndrome in the Middle East
Aliah Ali Khesroh1, Faisal Al-Roumi1, Ibrahim Al-Zakwani2, Sreeja Attur3, Wafa Rashed4, Mohammad Zubaid3
1 Department of Medicine, Al-Amiri Hospital, Kuwait 2 Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University and Oman Gulf Health Research, Muscat, Oman 3 Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait 4 Department of Medicine, Mubarak Al-Kabeer Hospital, Jabriya, Kuwait
Correspondence Address:
Aliah Ali Khesroh Senior Registrar, Internal Medicine, Al-Amiri Hospital, PO Box 26866, Safat 13001 Kuwait
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/HEARTVIEWS.HEARTVIEWS_10_17
|
|
Background: There is controversy regarding the relationship between gender and acute coronary syndrome (ACS). Objective: To study the impact of gender on presentation, management, and mortality among patients with ACS in the Middle East. Methodology: From January 2012 to January 2013, 4057 patients with ACS were enrolled from four Arabian Gulf countries (Kuwait, Oman, United Arab Emirates, and Qatar), representing more than 85% of the general hospitals in each of the participating countries. Results: Compared to men, women were older and had more comorbidities. They also had atypical presentation of ACS such as atypical chest pain and heart failure. The prevalence of non-ST-segment elevation myocardial infarction (49 vs. 46%; P < 0.001) and unstable angina (34 vs. 24%; P < 0.001) was higher among women as compared to men. In addition, women were less likely to receive evidence-based medications such as aspirin, clopidogrel, beta-blocker, and angiotensin-converting enzyme inhibitors on admission and on discharge. During hospital stay, women suffered more heart failure (15 vs. 12%; P = 0.008) and were more likely to receive blood transfusion (6 vs. 3%; P < 0.001). Women had higher 1-year mortality (14 vs. 11%; P < 0.001), the apparent difference that disappeared after adjusting for age and other comorbidities. Conclusion: Although there were differences between men and women in presentation, management, and in-hospital outcomes, gender was shown to be a nonsignificant contributor to mortality after adjusting for confounders. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|